GlassScriptPhysician profile
Jonathan Edward Bradd
NPI 1760034607
$6,431.25
in general payments reported to CMS, 2019-2025
39 companies · $1,299 in 2025
The $1,299 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,376 · 2022: $1,239 · 2023: $1,237 · 2024: $1,281 · 2025: $1,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,427 · Education: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,426.67 |
| Education | $390.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,093.63 | 2021-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $585.69 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $562.19 | 2021-2025 | Prolaris |
| Pfizer INC. | $455.83 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $405.95 | 2021-2025 | Provenge |
| Procept Biorobotics Corporation | $396.15 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Myovant Sciences INC. | $383.96 | 2021-2022 | |
| Janssen Biotech, INC. | $280.27 | 2021-2025 | Erleada, Akeega, Balversa |
| Astrazeneca Pharmaceuticals LP | $258.92 | 2021-2025 | Lynparza, Onglyza, Imfinzi |
| Abbvie INC. | $188.88 | 2021-2025 | |
| Telix Pharmaceuticals | $183.99 | 2024 | Illuccix |
| Endo Pharmaceuticals INC. | $172.16 | 2021-2023 | Aveed, Xiaflex, Edex |
| Urogen Pharma, INC. | $139.83 | 2022-2025 | Jelmyto |
| Tolmar, INC. | $130.80 | 2023-2025 | Eligard, Jatenzo |
| Boston Scientific Corporation | $115.97 | 2021-2025 | Rezum Generator, Lithovue |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $101.27 | 2021-2025 | |
| Seagen INC. | $93.00 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $88.48 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $86.41 | 2025 | |
| Accord Healthcare, INC. | $79.49 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $63.81 | 2023-2024 | Keytruda, Lynparza |
| Blue Earth Diagnostics | $58.45 | 2021-2022 | |
| Olympus America INC. | $46.54 | 2022-2024 | Itind System |
| Verity Pharmaceuticals INC. | $41.11 | 2022-2025 | Trelstar |
| Janssen Scientific Affairs, LLC | $39.90 | 2024 | Akeega, Erleada |
| Axonics, INC. | $37.39 | 2023-2024 | Bulkamid, Axonics |
| Amgen INC. | $36.46 | 2021-2023 | Prolia |
| Immunitybio, INC. | $35.96 | 2025 | |
| Coloplast Corp | $33.23 | 2022-2023 | Speedicath |
| Endo USA, INC. | $30.10 | 2024-2025 | Xiaflex |
| Edap Technomed INC | $29.99 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $24.76 | 2024 | |
| Foundation Medicine, INC. | $24.36 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $24.02 | 2024 | Adstiladrin |
| Organon LLC | $22.35 | 2025 | |
| Koelis INC. | $21.71 | 2023 | |
| Laborie Medical Technologies Corp. | $20.93 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Genzyme Corporation | $20.35 | 2022 | |
| Davol INC. | $16.96 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bradd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.